Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML - Archive ouverte HAL Access content directly
Journal Articles Leukemia Year : 2012

Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML

Hélène Jammes

Abstract

absent
No file

Dates and versions

hal-01004302 , version 1 (11-06-2014)

Identifiers

Cite

S. S. Ettou, E. E. Audureau, C. C. Humbrecht, B. B. Benet, Hélène Jammes, et al.. Fas expression at diagnosis as a biomarker of azacitidine activity in high-risk MDS and secondary AML. Leukemia, 2012, 26 (10), pp.2297-2299. ⟨10.1038/leu.2012.152⟩. ⟨hal-01004302⟩
273 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More